(77 days)
Not Found
No
The summary explicitly states that the software algorithms for critical functions remain exactly the same as in the predicate devices, and there is no mention of AI, ML, or related terms.
No
The device is described as a "multi-purpose diagnostic ophthalmic ultrasound system" and its intended uses are "to make axial length, anterior chamber depth, lens thickness and corneal thickness measurements" and "visualize the internal structure of the eye." These functions are diagnostic, not therapeutic.
Yes
The "Intended Use / Indications for Use" section explicitly states that "The 4Sight is a multi-purpose diagnostic ophthalmic ultrasound system".
No
The device description explicitly states it is a "stand-alone system which runs on a Windows 8 platform consisting of a 4Sight control unit, transducers, footswitch, and keyboard," indicating it includes hardware components beyond just software.
Based on the provided information, the 4Sight device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
- 4Sight's Function: The 4Sight device uses ultrasound to directly measure and visualize the internal structures of the eye. It does not analyze samples taken from the body.
- Intended Use: The intended use clearly states it's for making measurements and visualizing the internal structure of the eye, which is an in vivo (within the living body) process, not in vitro (in glass or outside the body).
- Device Description: The description confirms it's an ultrasound system with transducers that interact directly with the eye.
Therefore, the 4Sight is a diagnostic medical device, but it falls under the category of in vivo diagnostic imaging and measurement systems, not in vitro diagnostics.
N/A
Intended Use / Indications for Use
The 4Sight is a multi-purpose diagnostic ophthalmic ultrasound system intended to make axial length, anterior chamber depth, lens thickness and corneal thickness measurements of the internal structure of the eye.
System: 4Sight
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
- Clinical Application: Ophthalmic
- Specific: Ophthalmic
- Mode of Operation: A
System: 4Sight Transducer: Pachymeter
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
- Clinical Application: Ophthalmic
- Specific: Ophthalmic
- Mode of Operation: A
System: 4Sight Transducer: A-scan
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
- Clinical Application: Ophthalmic
- Specific: Ophthalmic
- Mode of Operation: A
System: 4Sight Transducer: B-scan
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
- Clinical Application: Ophthalmic
- Specific: Ophthalmic
- Mode of Operation: P
The 4Sight is a multi-purpose diagnostic ophthalmic ultrasound system intended to make axial length, anterior chamber depth, lens thickness and corneal thickness measurements of the eye and visualize the internal structure of the eye.
Product codes (comma separated list FDA assigned to the subject device)
IYO, ITX
Device Description
The 4sight device is designed to combine the functionalities of Accutome's A-scan Plus (K123349), B-scan Plus (K070943) and Accupach Pachymeter (K042752) devices into a combined, stand-alone platform.
The device performs axial length measurements, corneal thickness measurements and images the internal structure of the eye using these 3 modalities.
The 4Sight is a stand-alone system which runs on a Windows 8 platform consisting of a 4Sight control unit, transducers, footswitch, and keyboard.
The 4Sight control unit consists of (4) printed circuit boards enclosed in a plastic case. This includes a 1 PCB for power management, 1 PCB to control the pachymeter function, 1 PCB to control the A-scan function and 1 PCB to act as a connector board. The PCB for A-scan functionality is unchanged from the A-scan Plus Connect predicate device.
The energy source for the 4Sight is AC to DC adapter used to power the Accupach Pachymeter predicate device.
Mentions image processing
Yes
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Ultrasonic pulsed echo imaging system
Anatomical Site
Internal structure of the eye
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Standards Testing:
- EN 60601-1 Medical Electronic Equipment Part 1: General Requirements for Safety. Both this device and the predicates were tested to, and found to be compliant with EN 60601-1.
- EN 60601-1-2 Collateral Standard: Electromagnetic Compatibility – Requirements and Tests. Both this device and the predicate were tested to, and found to be compliant with EN 60601-1-2.
- IEC 60601-2-37 - Safety of Ultrasonic Medical Diagnostic and Monitoring Equipment. Acoustic Measurements for the predicate devices have been evaluated by Acertara Laboratories and Sonora Laboratories.
- EN/ISO 10993 - Biological Evaluation of Medical Devices. The same probes are used with this device as with the predicate device which were tested to ISO10993; the materials have not changed.
Verification Testing:
- A-scan Physical Accuracy Test: This test compares the distance measured ultrasonically by the A-Scan function on the 4sight and the physical distance measured by a mechanical dial indicator.
Results: Both the A-scan Plus Connect model and the predicate device were well within the 0.1mm acceptance criteria. - Pachymetry Comparison Test: Accupach VI (predicate) vs. 4Sight. The objective of this test is to compare critical parameter results between the two devices under conditions of the same input test fixture and values.
Results: All of the data met the established acceptance criteria.
Internal Validation Tests: A test plan was developed to evaluate proper operation and usability for all device modes/options.
Results: All operations and features were fully functional. There were no errors or deficiencies in the patient information. The usability was judged to be equivalent to the predicate device.
Software Validation Testing: 317 software requirements specified in the software requirement specification were tested and validated during the software validation process. All software bugs discovered during the validation process, with the exception of one minor anomaly, were corrected during the process.
External Validation Tests: A checklist was developed which requests quantified critique regarding the safety, functionality and usability of the device. A Rating Scale from 1 to 5 was used with: 5 = best, very user friendly, no problems; and 1 = not acceptable, very unfriendly, significant problem that must be corrected.
Results: The device was evaluated at 4 different locations by experienced technicians/ophthalmologists. Safety was ranked 5 by every user. The "Overall Rating" of the device was 4 or 5 by all users. There were no ratings of 1 or 2 in any of the tests.
Validation Tests Summary: The internal and external validation tests demonstrate along with risk analysis and testing to applicable standards that there are no known safety issues with the 4Sight device. The tests further demonstrate that there are no significant functionality issues and that the usability of the device is equivalent to that of the predicate device.
Conclusion: The positive results of the testing above, along with the risk analysis performed, demonstrate that the 4Sight is at least as safe and as effective as the predicate devices.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 892.1560 Ultrasonic pulsed echo imaging system.
(a)
Identification. An ultrasonic pulsed echo imaging system is a device intended to project a pulsed sound beam into body tissue to determine the depth or location of the tissue interfaces and to measure the duration of an acoustic pulse from the transmitter to the tissue interface and back to the receiver. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.(b)
Classification. Class II (special controls). A biopsy needle guide kit intended for use with an ultrasonic pulsed echo imaging system only is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 892.9.
0
Image /page/0/Picture/1 description: The image shows the logo for the Department of Health & Human Services - USA. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is a stylized symbol featuring three abstract human profiles facing to the right, with flowing lines suggesting movement or connection.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
November 25, 2015
Accutome, Inc. % Mr. Adam Pickholtz Quality/Regulatory Manager 3222 Phoenixville Pike MALVERN PA 19355
Re: K152573 Trade/Device Name: 4Sight Regulation Number: 21 CFR 892.1560 Regulation Name: Ultrasonic pulsed echo imaging system Regulatory Class: II Product Code: IYO, ITX Dated: October 28, 2015 Received: October 30, 2015
Dear Mr. Pickholtz:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21. Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
1
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638 2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
Robert Oels
Robert Ochs. Ph.D. Director Division of Radiological Health Office of In Vitro Diagnostics and Radiological Health Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K152573
Device Name 4Sight
Indications for Use (Describe)
The 4Sight is a multi-purpose diagnostic ophthalmic ultrasound system intended to make axial length, anterior chamber depth, lens thickness and corneal thickness measurements of the internal structure of the eye.
Type of Use (Select one or both, as applicable)
Prescription Use (Part 21 CFR 801 Subpart D)
Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
Form Approved: OMB No. 0910-0120 Expiration Date: January 31, 2017 See PRA Statement below.
3
4Sight 510(k) Notification
System: 4Sight
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
| Clinical Application | Mode of Operation | |||||||
|---|---|---|---|---|---|---|---|---|
| General | ||||||||
| (Track 1 Only) | Specific | |||||||
| (Tracks 1 & 3) | B | M | PWD | CWD | Color | |||
| Doppler | Combined (A, B) | A | ||||||
| Ophthalmic | Ophthalmic | P |
System: 4Sight Transducer: Pachymeter
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
| Clinical Application | Mode of Operation | |||||||
|---|---|---|---|---|---|---|---|---|
| General | ||||||||
| (Track 1 Only) | Specific | |||||||
| (Tracks 1 & 3) | B | M | PWD | CWD | Color | |||
| Doppler | Combined | |||||||
| (Specify) | A | |||||||
| Ophthalmic | Ophthalmic | P |
System: 4Sight Transducer: A-scan -------------------
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
| Clinical Application | Mode of Operation | ||||||
|---|---|---|---|---|---|---|---|
| General | |||||||
| (Track 1 Only) | Specific | ||||||
| (Tracks 1 & 3) | B M | PWD | CWD | Color | |||
| Doppler | Combined | ||||||
| (Specify) | A | ||||||
| Ophthalmic | Ophthalmic | P |
System: 4Sight Transducer: B-scan
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
| Clinical Application | Mode of Operation | ||||
|---|---|---|---|---|---|
| General | |||||
| (Track 1 Only) | Specific | ||||
| (Tracks 1 & 3) | B M PWD CWD | Color | |||
| Doppler | Combined | ||||
| (Specify) | A | ||||
| Ophthalmic | Ophthalmic | P |
4
Image /page/4/Picture/1 description: The image shows the logo for Accutome. The logo features a dark blue circle with a white triangle inside, resembling the number 4. Below the circle, the word "ACCUTOME" is written in a bold, sans-serif font, also in dark blue.
510(k) SUMMARY: 4Sight
| Applicant: | Accutome, Inc. |
|---|---|
| Address: | 3222 Phoenixville Pike |
| Malvern, PA 19355 | |
| Contact Person: | Adam Pickholtz |
| Manager QA/QC | |
| Telephone: | (610) 889-0200 |
| (610) 889-3233 Fax | |
| Preparation Date: | 8/10/15 |
| Trade Name: | 4Sight |
| Common Name: | Ophthalmic Diagnostic Ultrasound System |
| Classification Name: | System, Imaging, Pulsed Echo, Ultrasonic |
| (21 CFR 892.1560, Product Code: IYO) | |
| Diagnostic Ultrasound Transducer | |
| (21 CFR 892.1570, Product Code: ITX) | |
| Legally Marketed | |
| Predicate Devices: | A-Scan Plus Connect (K123349) |
| B-scan Plus (K070943) | |
| Accupach V Pachymeter (K042752) | |
| ● No prior FDA submissions have been submitted for a | |
| combination unit by Accutome, Inc. | |
| Description of the Device: | The 4sight device is designed to combine the |
| functionalities of Accutome's A-scan Plus (K123349), B- | |
| scan Plus (K070943) and Accupach Pachymeter (K042752) | |
| devices into a combined, stand-alone platform. |
5
The device performs axial length measurements, corneal thickness measurements and images the internal structure of the eye using these 3 modalities.
The 4Sight is a stand-alone system which runs on a Windows 8 platform consisting of a 4Sight control unit, transducers, footswitch, and keyboard.
The 4Sight is a multi-purpose diagnostic ophthalmic Indications for Use: ultrasound system intended to make axial length, anterior chamber depth, lens thickness and corneal thickness measurements of the eye and visualize the internal structure of the eye.
Comparison of Technological Characteristics to the predicate device:
All of the critical functions of the 4Sight device are calculated in exactly the same manner as in the predicate devices. The Ascan, B-scan, and pachymetry probes used with the 4Sight are exactly the same as the probe used on the predicate devices. The software algorithms for clinically critical functions, i.e. to process ultrasound measurements and calculate intraocular lens parameters remain exactly the same as in the predicate devices.
The new standalone 4Sight model uses a standalone control unit as the main computing vehicle and display instead of the personal computer. The software modifications in the 4sight model are those necessary to interface the processing, data storage, display, and printing capabilities of a combined, standalone control unit.
The 4Sight control unit consists of (4) printed circuit boards enclosed in a plastic case. This includes a 1 PCB for power management, 1 PCB to control the pachymeter function, 1 PCB to control the A-scan function and 1 PCB to act as a connector board. The PCB for A-scan functionality is unchanged from the A-scan Plus Connect predicate device.
The energy source for the 4Sight is AC to DC adapter used to power the Accupach Pachymeter predicate device.
6
| | The chemical composition of patient contact materials is
identical to that of the predicate device as the probes have not
changed. |
|-----------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Standards Testing: | EN 60601-1 Medical Electronic Equipment Part 1: General
Requirements for Safety
Both this device and the predicates were tested to, and found to
be compliant with EN 60601-1. |
| | EN 60601-1-2 Collateral Standard: Electromagnetic
Compatibility – Requirements and Tests
Both this device and the predicate were tested to, and found to
be compliant with EN 60601-1-2. |
| | IEC 60601-2-37 - Safety of Ultrasonic Medical Diagnostic and
Monitoring Equipment
Acoustic Measurements for the predicate devices have been
evaluated by Acertara Laboratories and Sonora Laboratories. |
| | EN/ISO 10993 - Biological Evaluation of Medical Devices
The same probes are used with this device as with the predicate
device which were tested to ISO10993; the materials have not
changed. |
| Verification Testing: | A-scan Physical Accuracy Test
This test compares the distance measured ultrasonically by the
A-Scan function on the 4sight and the physical distance
measured by a mechanical dial indicator. The test results for
both the A-Scan function and the predicate device were well
within the 0.1mm acceptance criteria. |
| | Results:
Both the A-scan Plus Connect model and the predicate device
were well within the 0.1mm acceptance criteria. |
| | Pachymetry Comparison Test: Accupach VI (predicate) vs.
4Sight
The objective of this test is to compare critical parameter
results between the two devices under conditions of the same
input test fixture and values. |
| | Results: |
7
All of the data met the established acceptance criteria
Internal Validation Tests Validation Testing:
A test plan was developed to evaluate proper operation and usability for all device modes/options.
Results:
All operations and features were fully functional. There were no errors or deficiencies in the patient information. The usability was judged to be equivalent to the predicate device.
Software Validation Testing
317 software requirements specified in the software requirement specification were tested and validated during the software validation process.
All software bugs discovered during the validation process, with the exception of one minor anomaly, were corrected during the process.
External Validation Tests
A checklist was developed which requests quantified critique regarding the safety, functionality and usability of the device. A Rating Scale from 1 to 5 was used with: 5 = best, very user friendly, no problems; and 1 = not acceptable, very unfriendly, significant problem that must be corrected.
Results:
The device was evaluated at 4 different locations by experienced technicians/ophthalmologists.
Safety was ranked 5 by every user. The "Overall Rating" of the device was 4 or 5 by all users. There were no ratings of 1 or 2 in any of the tests.
Validation Tests Summary
The internal and external validation tests demonstrate along with risk analysis and testing to applicable standards that there are no known safety issues with the 4Sight device.
8
The tests further demonstrate that there are no significant functionality issues and that the usability of the device is equivalent to that of the predicate device.
Conclusion:
The positive results of the testing above, along with the risk analysis performed, demonstrate that the 4Sight is at least as safe and as effective as the predicate devices.